Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL2316458

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1cnc(C(=O)[C@H](C[C@@H]2CCNC2=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)COc2cccc(N(C)C)c2)C(C)C)s1

Basic Information

ChEMBL ID CHEMBL2316458
Phase Preclinical
Structure Type MOL
InChI Key CEZLCCHFGRIUBL-DJESZUOASA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

642.8
MW (Da)
2.46
ALogP
9
HBA
4
HBD
158.8
PSA (Ų)
0.20
QED
1
Ro5 Violations
16
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C32H46N6O6S
MW 642.82
Aromatic Rings 2
Heavy Atoms 45
NP-Likeness -0.58

Activity Summary

Ki 1 meas. best 6.48

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
Ki 6.48 6.48 330.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked Ki = 330.0 nM 6.48 Inhibition of SARS coronavirus 3C-like protease R188I mutant using Dabcyl- KTSAV... 23245752

Literature References

PubMed DOI Target Context # Activities
23245752 10.1016/j.bmc.2012.11.017 Unchecked 1

Data from ChEMBL 36 via Core Engine